Adcentrx Therapeutics
Adcentrx Therapeutics is a clinical-stage biotechnology company headquartered in San Diego, California, developing next-generation antibody-drug conjugates (ADCs) and protein conjugate therapeutics for cancer and other life-threatening diseases. Its proprietary i-Conjugation technology platform pairs stable conjugation chemistry and protease-cleavable linkers with novel small-molecule payloads; the clinical pipeline includes ADRX-0706 (Nectin-4) and ADRX-0405 (STEAP1). The company was surfaced via the API Evangelist harvest backlog (source: secondary-market). It publishes a corporate and investor-relations website only — no developer program, API, SDK, or machine-readable specification of any kind was found.
Adcentrx Therapeutics is profiled on the APIs.io network. Tagged areas include Company, Biotechnology, Pharmaceuticals, Life Sciences, and Oncology.
Adcentrx Therapeutics’ developer surface includes engineering blog, support, and 7 more developer resources.
Kin Score
Security Posture 1
Authentication, domain security, vulnerability disclosure, and trust-center signals.
Resources
Access & Security 1
Authentication, authorization, and security posture
Operate 1
Status, limits, changes, and where to get help
Commercial 2
Pricing, plans, and the legal terms of use
Company 5
The organization behind the API
Source (apis.yml)
Work with this as data
Every provider here is available over the APIs.io API and to AI agents over MCP.